CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in ACRS — Aclaris Therapeutics, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in ACRS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$978,712
+$122,054 QoQ
Shares Held
260,990
-8.3% QoQ
Ownership
0.187%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ACRS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $6,182,986,350 across 288 Biotechnology names. ACRS ranks #204 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,920,871 | $857,745,736 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
804,508 | $621,595,061 | |
| 3 | MRNA |
Moderna, Inc.
|
4,734,356 | $240,505,284 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
673,356 | $222,793,299 | |
| 5 | INSM |
INSMED Inc
|
1,069,390 | $174,866,652 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
1,735,476 | $168,775,041 | |
| 7 | INCY |
Incyte Corp
|
1,729,102 | $162,743,080 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,976,094 | $146,744,740 |
All Filings in ACRS
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $978,712 | 260,990 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $856,658 | 284,604 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $459,716 | 241,956 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $371,043 | 261,298 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $50,610 | 33,079 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $82,035 | 33,079 | Shares | Sole | 2025-02-06 | |
| 2024-06-30 | $286,776 | 260,706 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $519,974 | 419,334 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $458,146 | 436,330 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $3,173,152 | 463,234 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $4,606,986 | 444,261 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $3,318,679 | 410,220 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $6,491,094 | 412,133 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $6,336,199 | 402,554 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,154,293 | 154,319 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,294,092 | 133,068 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,874,395 | 128,913 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $2,284,488 | 126,916 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $1,893,635 | 107,838 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $397,882 | 15,789 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $132,667 | 20,505 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $52,697 | 20,505 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $33,218 | 20,505 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $88,090 | 84,702 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||